Progressive Care: PharmCo Receives State Licenses from New
Jersey and Pennsylvania
MIAMI, FL -- July 25, 2016 -- InvestorsHub NewsWire --
Progressive Care Inc. (OTC
PINK: RXMD), through its subsidiary Pharmco LLC, a South
Florida health services organization and provider of prescription
pharmaceuticals specializing in health practice risk management,
compounded medications, the sale of anti-retroviral medications and
related medication therapy management, and the supply of
prescription medications to long term care facilities, announces
the receipt of two new state licenses.
On July 21, 2016, the states of New Jersey and Pennsylvania
granted non-resident pharmacy licenses to PharmCo, LLC. These
licenses allow PharmCo to dispense traditional and compounded
medications to the residents of these states from the Companys
current facility. The Company is already conducting business in
three other states: New York, Texas, and Florida.
We are excited to have the opportunity to service patients in
New Jersey and Pennsylvania and continue to build the PharmCo
brand, stated S. Parikh Mars, CEO. The Company has pending
applications in numerous other states including Georgia and
Illinios. We are looking forward to expanding our reach and
delivering exceptional products and service to patients across the
United States
Common Shares Issued and Outstanding:
As of
July 14, 2016 the number shares of common stock issued and
outstanding stood at 341,107,607 shares. This amount is net of the
number of shares owned by PharmCo, LLC of 1,718,000.
About Progressive Care
Progressive Care, Inc. (OTC
PINK: RXMD), through its subsidiary PharmCo, LLC, is a South
Florida health services organization and provider of prescription
pharmaceuticals specializing in health practice risk management,
compounded medications, the sale of anti-retroviral medications and
related medication therapy management, and the supply of
prescription medications to long term care facilities.
Cautionary Statement Regarding Forward Looking Statements
Statements contained herein that are not based upon current or
historical fact are forward-looking in nature and constitute
forward-looking statements within the meaning of Section 27A of the
Securities Act of 1933 and Section 21E of the Securities Exchange
Act of 1934. Such forward-looking statements reflect the Companys
expectations about its future operating results, performance and
opportunities that involve substantial risks and uncertainties.
These statements include but are not limited to statements
regarding the intended terms of the offering, closing of the
offering and use of any proceeds from the offering. When used
herein, the words anticipate, believe, estimate, upcoming, plan,
target, intend and expect and similar expressions, as they relate
to Progressive Care Inc., its subsidiaries, or its management, are
intended to identify such forward-looking statements. These
forward-looking statements are based on information currently
available to the Company and are subject to a number of risks,
uncertainties, and other factors that could cause the Company's
actual results, performance, prospects, and opportunities to differ
materially from those expressed in, or implied by, these
forward-looking statements.
Contact
Armen Karapetyan
Senior Advisor Business Development
armen@progressivecareus.com